Prenatal Gene Editing for Neurodevelopmental Diseases: Ethical Considerations
January 30, 2025
Tag: Eric Juengst
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing
July 23, 2024
Dr. Eric Juengst, Renowned Bioethicist and UNC Professor, Announces Retirement
February 1, 2024
After a distinguished career at the forefront of bioethics, Professor Eric Juengst, PhD, is set to embark on a well-deserved retirement. Although stepping back from his full-time role, Dr. Juengst will continue as an emeritus professor, maintaining the flexibility to attend lectures and participate in research at his discretion—a self-coined...
The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research
June 29, 2023
Public Health Research Using Cell Phone Derived AUTHORS: Mobility Data in Sub-Saharan Africa: Ethical issues
June 29, 2023
Improving the Continuity of Care for People Living with HIV Experiencing Incarceration in North Carolina Jails: Stakeholder Perspectives.
September 1, 2022
Scientists’ Views on Scientific Self-Governance for Human Genome Editing Research
August 19, 2022
Advancing a Data Justice Framework for Public Health Surveillance
April 20, 2022
Juengst awarded Kenan Research Leave for Spring, 2022
December 6, 2021
The UNC Provost’s Office has awarded Eric Juengst a Kenan Foundation-supported university sabbatical for the Spring Semester of 2022. Juengst will pursue research exploring the revival of scientific interest in “good” human genes, by examining different forms of beneficial genomic variant research and their ethical and social implications. Kenan Research...
The View from the Benches: Scientists’ Perspectives on the Uses and Governance of Human Gene-Editing Research
August 26, 2021
The advent of human gene editing has stimulated international interest in how best to govern this research. However, research on stakeholder views has neglected scientists themselves. We surveyed 212 scientists who use gene editing in their work. Questions captured views on oversight and use of somatic and germline human gene...